Lataa...
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies
Osteosarcoma is the most common primary malignant bone tumor in children and young adults. The standard-of-care curative treatment for osteosarcoma utilizes doxorubicin, cisplatin, and high-dose methotrexate, a standard that has not changed in more than 40 years. The development of patient-specific...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000603/ https://ncbi.nlm.nih.gov/pubmed/33809018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10061182 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|